Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase III Trial of Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC)

Summary

The purpose of this phase III study is to evaluate the efficacy of of intra-arterial chemotherapy with gemcitabine vs. IV gemcitabine plus nab-paclitaxel among patients with locally advanced pancreatic adenocarcinoma which is unresectable.

General Information

NCT#: NCT03257033
Study ID: RR3
Trial Phase: Phase III

Trial Sponsor: RenovoRx
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, Radiation Therapy, Capecitabine

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search